Patents by Inventor Jonas Weinmann

Jonas Weinmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a Synthetic AAV Capsid for Gene Therapy of Muscle and Central Nervous System Disorders
    Publication number: 20230173102
    Abstract: The invention relates to the use of a recombinant porcine adeno-associated virus (AAV) vector comprising a peptide-modified porcine AAV serotype 1 (AAVpol) capsid in gene therapy of muscle and/or central nervous system (CNS) disorders, in particular neuromuscular diseases such as genetic neuromuscular diseases.
    Type: Application
    Filed: April 28, 2021
    Publication date: June 8, 2023
    Applicants: Genethon, Universität Heidelberg, Universite d'Evry val d'Essonne, Institut National de la Santé et de la Recherche Médicale
    Inventors: Ana Buj Bello, Edith Renaud-Gabardos, Dirk Grimm, Jonas Weinmann
  • MODIFIED AAV CAPSID POLYPEPTIDES FOR TREATMENT OF MUSCULAR DISEASES
    Publication number: 20210363193
    Abstract: Described herein is an adeno-associated virus (AAV) capsid polypeptide bonded to a binding peptide including an amino acid sequence RGDX1X2X3X4, with X1 to X4 being independently selected amino acids, for use in treating and/or preventing a muscular disease and/or in muscle regeneration. Also described are polynucleotides, host cells, adeno-associated virus (AAV) capsids, pharmaceutical compositions, uses, and methods related to the AAV capsid polypeptide.
    Type: Application
    Filed: April 26, 2019
    Publication date: November 25, 2021
    Inventors: Dirk Grimm, Jonas Weinmann, Josef El Andari